228 related articles for article (PubMed ID: 23419260)
1. Both K63 and K48 ubiquitin linkages signal lysosomal degradation of the LDL receptor.
Zhang L; Xu M; Scotti E; Chen ZJ; Tontonoz P
J Lipid Res; 2013 May; 54(5):1410-20. PubMed ID: 23419260
[TBL] [Abstract][Full Text] [Related]
2. Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible Degrader of the LDLR (IDOL).
Sorrentino V; Scheer L; Santos A; Reits E; Bleijlevens B; Zelcer N
J Biol Chem; 2011 Aug; 286(34):30190-9. PubMed ID: 21734303
[TBL] [Abstract][Full Text] [Related]
3. The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.
Nelson JK; Sorrentino V; Avagliano Trezza R; Heride C; Urbe S; Distel B; Zelcer N
Circ Res; 2016 Feb; 118(3):410-9. PubMed ID: 26666640
[TBL] [Abstract][Full Text] [Related]
4. The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation.
Sorrentino V; Nelson JK; Maspero E; Marques ARA; Scheer L; Polo S; Zelcer N
J Lipid Res; 2013 Aug; 54(8):2174-2184. PubMed ID: 23733886
[TBL] [Abstract][Full Text] [Related]
5. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.
Scotti E; Calamai M; Goulbourne CN; Zhang L; Hong C; Lin RR; Choi J; Pilch PF; Fong LG; Zou P; Ting AY; Pavone FS; Young SG; Tontonoz P
Mol Cell Biol; 2013 Apr; 33(8):1503-14. PubMed ID: 23382078
[TBL] [Abstract][Full Text] [Related]
6. Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.
Sorrentino V; Zelcer N
Curr Opin Lipidol; 2012 Jun; 23(3):213-219. PubMed ID: 22510808
[TBL] [Abstract][Full Text] [Related]
7. K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains.
Ohtake F; Tsuchiya H; Saeki Y; Tanaka K
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1401-E1408. PubMed ID: 29378950
[TBL] [Abstract][Full Text] [Related]
8. The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.
Zhang L; Fairall L; Goult BT; Calkin AC; Hong C; Millard CJ; Tontonoz P; Schwabe JW
Genes Dev; 2011 Jun; 25(12):1262-74. PubMed ID: 21685362
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake.
Nelson JK; Cook EC; Loregger A; Hoeksema MA; Scheij S; Kovacevic I; Hordijk PL; Ovaa H; Zelcer N
J Biol Chem; 2016 Feb; 291(9):4813-25. PubMed ID: 26719329
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding site.
Martinelli L; Adamopoulos A; Johansson P; Wan PT; Gunnarsson J; Guo H; Boyd H; Zelcer N; Sixma TK
J Biol Chem; 2020 Sep; 295(39):13570-13583. PubMed ID: 32727844
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1.
Wang JQ; Lin ZC; Li LL; Zhang SF; Li WH; Liu W; Song BL; Luo J
J Biol Chem; 2021; 296():100032. PubMed ID: 33154164
[TBL] [Abstract][Full Text] [Related]
12. cIAP1-based degraders induce degradation via branched ubiquitin architectures.
Akizuki Y; Morita M; Mori Y; Kaiho-Soma A; Dixit S; Endo A; Shimogawa M; Hayashi G; Naito M; Okamoto A; Tanaka K; Saeki Y; Ohtake F
Nat Chem Biol; 2023 Mar; 19(3):311-322. PubMed ID: 36316570
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists.
Scotti E; Hong C; Yoshinaga Y; Tu Y; Hu Y; Zelcer N; Boyadjian R; de Jong PJ; Young SG; Fong LG; Tontonoz P
Mol Cell Biol; 2011 May; 31(9):1885-93. PubMed ID: 21343340
[TBL] [Abstract][Full Text] [Related]
14. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
[TBL] [Abstract][Full Text] [Related]
15. ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination.
Marx C; Held JM; Gibson BW; Benz CC
Cancer Res; 2010 May; 70(9):3709-17. PubMed ID: 20406983
[TBL] [Abstract][Full Text] [Related]
16. IDOL, inducible degrader of low-density lipoprotein receptor, serves as a potential therapeutic target for dyslipidemia.
Zhang CP; Tian Y; Zhang M; Tuo QH; Chen JX; Liao DF
Med Hypotheses; 2016 Jan; 86():138-42. PubMed ID: 26601593
[TBL] [Abstract][Full Text] [Related]
17. The E3 ubiquitin ligase inducible degrader of the LDL receptor/myosin light chain interacting protein in health and disease.
van Loon NM; Lindholm D; Zelcer N
Curr Opin Lipidol; 2019 Jun; 30(3):192-197. PubMed ID: 30896554
[TBL] [Abstract][Full Text] [Related]
18. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.
Zhang L; Reue K; Fong LG; Young SG; Tontonoz P
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2541-6. PubMed ID: 22936343
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.
Harris LD; Le Pen J; Scholz N; Mieszczanek J; Vaughan N; Davis S; Berridge G; Kessler BM; Bienz M; Licchesi JDF
J Biol Chem; 2021; 296():100246. PubMed ID: 33853758
[TBL] [Abstract][Full Text] [Related]
20. Ubiquiton-An inducible, linkage-specific polyubiquitylation tool.
Renz C; Asimaki E; Meister C; Albanèse V; Petriukov K; Krapoth NC; Wegmann S; Wollscheid HP; Wong RP; Fulzele A; Chen JX; Léon S; Ulrich HD
Mol Cell; 2024 Jan; 84(2):386-400.e11. PubMed ID: 38103558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
